SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056699
Filing Date
2021-11-12
Accepted
2021-11-12 16:01:52
Documents
48
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20210930.htm   iXBRL 10-Q 2568114
2 EX-31.1 life-ex311_7.htm EX-31.1 9629
3 EX-31.2 life-ex312_8.htm EX-31.2 9125
4 EX-32.1 life-ex321_6.htm EX-32.1 5509
5 EX-32.2 life-ex322_9.htm EX-32.2 5498
  Complete submission text file 0001564590-21-056699.txt   7215244

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA life-20210930.xsd EX-101.SCH 38956
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20210930_cal.xml EX-101.CAL 42479
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20210930_def.xml EX-101.DEF 136072
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20210930_lab.xml EX-101.LAB 324361
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20210930_pre.xml EX-101.PRE 236025
11 EXTRACTED XBRL INSTANCE DOCUMENT life-10q_20210930_htm.xml XML 1244684
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 211403221
SIC: 2836 Biological Products, (No Diagnostic Substances)